OnKure Therapeutics, Inc.
OKUR
$2.82
-$0.015-0.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | 3.71M | 3.99M | 4.11M | 3.59M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 16.32M | 17.00M | 17.85M | 13.72M | |
| Operating Income | -16.32M | -17.00M | -17.85M | -13.72M | |
| Income Before Tax | -15.39M | -15.93M | -17.44M | -14.14M | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -15.39M | -15.93M | -17.44M | -14.14M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -15.39M | -15.93M | -17.44M | -14.14M | |
| EBIT | -16.32M | -17.00M | -17.85M | -13.72M | |
| EBITDA | -16.21M | -16.88M | -17.74M | -13.61M | |
| EPS Basic | -1.14 | -1.19 | -1.37 | -44.82 | |
| Normalized Basic EPS | -0.71 | -0.74 | -0.81 | -26.78 | |
| EPS Diluted | -1.14 | -1.19 | -1.37 | -44.82 | |
| Normalized Diluted EPS | -0.71 | -0.74 | -0.81 | -26.78 | |
| Average Basic Shares Outstanding | 13.51M | 13.42M | 12.77M | 315.50K | |
| Average Diluted Shares Outstanding | 13.51M | 13.42M | 12.77M | 315.50K | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |